Monthly Archives: January 2023

DC indefiniteness finding vacated and remanded, while “means”-related claim construction finding affirmed, each based on the intrinsic evidence

Grace Instrument Industries, LLC v. Chandler Instruments Co., LLC and Ametek, Inc. Docket No. 2021-2370 ( CHEN, CUNNINGHAM, STARK January 12, 2023 Brief Summary:   DC indefiniteness determination of “enlarged chamber” vacated and remanded while construction of “means for driving” … Continue reading

Posted in Claim Construction, Indefiniteness, Means-plus-function | Leave a comment

Novartis appeals to SCOTUS rehearing of FC panel decision reversing negative limitation written description finding of prior FC panel

Novartis Pharm. Corp. v. Accord Healthcare, et al. and HEC Pharm Co., Ltd. et al. Docket No. 2021-1070 ( MOORE (D), LINN, O’MALLEY January 24, 2022 Second Update (January 24, 2023): Novartis petitioned SCOTUS with two questions presented:  1) Whether … Continue reading

Posted in Appeal, Negative Limitations, U.S. Supreme Court, Written description | Leave a comment

DC prosecution laches finding affirmed (unreasonable and inexcusable delay by PMC and prejudice to Apple)

Personalized Media Communications, LLC v. Apple Inc. Docket No. 2021-2275 ( REYNA, CHEN, STARK January 20, 2023 Brief Summary:   DC decision of prosecution laches (unreasonable and inexcusable delay by PMC and prejudice to Apple) affirmed. Summary:  Personalized Media Communications … Continue reading

Posted in Equitable estoppel, Laches, Prosecution History Estoppel, Uncategorized | Leave a comment

FC panel affirms DC obviousness and non-infringement findings regarding Genentech’s Esbriet® patents

Genentech, Inc., Intermune, Inc. v. Sandoz Inc., LEK Pharmaceuticals, D.D. Docket No. 2022-1595 ( NEWMAN, LOURIE, PROST December 22, 2022 Brief Summary:   DC findings that Genetech’s disputed Esbriet® patents are invalid for obviousness and not infringed by Sandoz’s ANDA … Continue reading

Posted in Generics / ANDA, Infringement, Method claims, Obviousness, Obviousness (Secondary Considerations) | Leave a comment

FC panel affirms Board IPR decisions finding P Tech’s robotic surgical instrument claims obvious

P Tech, LLC v. Intuitive Surgical, Inc. Docket No. 2022-1102, -1115 (IPR-2020-00649-50) ( (Non-Precedential) LOURIE, DYK, CUNNINGHAM December 15, 2022 Brief Summary:   Board IPR decisions of obviousness of P Tech’s robotic surgical instrument claims affirmed. Summary:  P Tech appealed … Continue reading

Posted in Appeal, Claim Construction, Inter Parties Review (IPR), IPR, Obviousness | Leave a comment